Sexual Risk Behavior in HIV-Infected Injection Drug Users

Battegay, Manuel; Bucher, Heiner C.; Vernazza, Pietro
April 2004
Clinical Infectious Diseases;4/15/2004, Vol. 38 Issue 8, p1175
Academic Journal
Injection drug use continues to be a very important mode of transmission of HIV infection, particularly in Asia, Eastern Europe, and South America, where effective needle-exchange programs and access to antiretroviral therapy for injection drug users (IDUs) are often limited. An important concern is the reports of increased sexual risk-taking among HIV-infected individuals, in particular among IDUs receiving HAART. Engaging in unsafe sex prior to initiation of HAART was associated with engaging in unprotected sex after initiation of HAART.


Related Articles

  • Survival of HIV-Infected Injection Drug Users (IDUs) in the Highly Active Antiretroviral Therapy Era, Relative to Sex- and Age-Specific Survival of HIV-Uninfected IDUs. Muga, Roberto; Langohr, Klaus; Tor, Jordi; Sanvisens, Arantza; Serra, Isabel; Rey-Joly, Celestino; Muñoz, Álvaro // Clinical Infectious Diseases;8/1/2007, Vol. 45 Issue 3, p370 

    Background. In the era of highly active antiretroviral therapy (HAART), it remains unclear whether human immunodeficiency virus (HIV)—infected injection drug users (IDUs) have durations of survival similar to those for comparable HIV-uninfected IDUs. The goal of this study was to compare...

  • New Approaches to Antiretroviral Drug Delivery: Challenges and Opportunities Associated with the Use of Long-Acting Injectable Agents. Boffito, Marta; Jackson, Akil; Owen, Andrew; Becker, Stephen // Drugs;Jan2014, Vol. 74 Issue 1, p7 

    Research on improved treatment of HIV infection and pre-exposure prophylaxis continues. Poor adherence to treatment is the critical risk factor for virological failure and resistance development, and long-acting formulations of anti-HIV medications that need only infrequent dosing may facilitate...

  • "I will not let my HIV status stand in the way." Decisions on motherhood among women on ART in a slum in Kenya- a qualitative study. Ujiji, Opondo Awiti; Ekström, Anna Mia; Ilako, Festus; Indalo, Dorcas; Rubenson, Birgitta // BMC Women's Health;2010, Vol. 10, p13 

    Background: The African Medical Research Foundation antiretroviral therapy program at the community health centre in Kibera counsels women to wait with pregnancy until they reach the acceptable level of 350 cells/ml CD4 count and to discuss their pregnancy intentions with their health care...

  • Overcoming the False Dichotomy of Curative vs Palliative Care for Late-Stage HIV/AIDS: "Let Me Live the Way I Want to Live, Until I Can't". Selwyn, Peter A.; Forstein, Marshall // JAMA: Journal of the American Medical Association;8/13/2003, Vol. 290 Issue 6, p806 

    Recent advances in human immunodeficiency virus (HIV) therapy have significantly reduced HIV-related mortality in the developed world, but mortality rates have plateaued, and AIDS remains a leading cause of serious illness and death for young adults. The chronic nature of the HIV disease course...

  • Current Management Challenges in HIV: Tolerability of Antiretrovirals and Metabolic Complications. Hicks, Charles; Currier, Judith; Sax, Paul; Sherer, Renslow; Wanke, Christine // AIDS Patient Care & STDs;May2003, Vol. 17 Issue 5, p221 

    The use of antiretroviral therapy for HIV infection has led to substantial reductions in morbidity and mortality. Many regimens, such as those combining three or more antiretroviral agents, result in near-complete suppression of HIV replication. Increased attention to short- and long-term...

  • High Levels of Primary Antiretroviral Resistance Genotypic Mutations And B/F Recombinants in Santos, Brazil. Sucupira, Maria Cecilia Araripe; Caseiro, Marcos Montani; Alves, Katia; Tescarollo, Graziela; Janini, Luiz Mario; Sabino, Ester Cerdeira; Castelo, Adauto; Page-Shafer, Kim; Diaz, Ricardo Sobhie // AIDS Patient Care & STDs;Feb2007, Vol. 21 Issue 2, p116 

    This study characterized HIV-1 among antiretroviral-naïve populations presenting recent infection (RI) or long-standing infection (LSI). Sera collected from January 1999 to December 2001 at an anonymous HIV testing site in Santos, Brazil, were submitted to serologic testing algorithm for...

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Jun99, Vol. 13 Issue 6, p375 

    Reports on developments in antiviral treatments against HIV and AIDS. Includes the United States and Canadian health authorities' approval of 3TC and efivirenz; Efficacy of antiviral agent HE2000 in lowering viral load; Triple-drug regimen of lamivudine, zidovudine and ritonavir to clear HIV...

  • A Fusion Inhibitor (FP-21399) for the Treatment of Human Immunodeficiency Virus Infection: A Phase I Study. Dezube, Bruce J.; Dahl, Thomas A.; Wong, Thomas K.; Chapman, Beryl; Ono, Mitsunori; Yamaguchi, Naoto; Gillies, Stephen D.; Lan Bo Chen; Crumpacker, Clyde S. // Journal of Infectious Diseases;8/1/2000, Vol. 182 Issue 2 

    Examines the risk for preventable opportunistic infections (Pneumocystis carinii pneumonia and Mycobacterium avium for persons with AIDS. Analysis on the effect of antiretroviral therapy for AIDS patients; Application of the counting-process formulation of the Cox model; Considerations for the...

  • The Search for Data on When to Start Treatment for HIV Infection. Hughes, Michael D.; Ribaudo, Heather R. // Journal of Infectious Diseases;4/15/2008, Vol. 197 Issue 8, p1034 

    The author presents the data gathered by the Strategies for Management of Antiretroviral Therapy (SMART) which are relevant to the potential application of antiretroviral therapy (ART) for infection with HIV. The study reveals that HIV-infected subjects who immediately initiated ART have...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics